Dashboard
Manage Tickers

MCK


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Evercore Says McKesson Wins OptumRX Contra...
04/22/2024 13:18:55

- Bloomberg

jim-cramer-is-willing-to-let-this-pharma-stock-catch-fire-advises-not-to-sell-mckesson
Jim Cramer Is 'Willing To Let This Pharma ...
04/19/2024 12:46:13

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

morgan-stanley-maintains-overweight-on-mckesson-raises-price-target-to-548
Morgan Stanley Maintains Overweight on McK...
04/15/2024 16:40:06

Morgan Stanley analyst Erin Wright maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $522 to ...

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-500-today
If You Invested $100 In This Stock 5 Years...
04/10/2024 21:30:38

argus-research-maintains-buy-on-mckesson-raises-price-target-to-570
Argus Research Maintains Buy on McKesson, ...
04/10/2024 15:23:34

Argus Research analyst David Toung maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $510 to $570.

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-3200-today
If You Invested $1000 In This Stock 10 Yea...
04/03/2024 17:00:25

peering-into-mckessons-recent-short-interest
Peering Into McKesson's Recent Short Interest
03/28/2024 14:15:11

rite-aid-forges-path-to-financial-recovery-with-major-settlement-report
Rite Aid Forges Path To Financial Recovery...
03/27/2024 09:54:55

Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters repor...

mccormick-reaffirms-fy24-sales-growth-outlook-of-2---0-adj-eps-of-280---285-vs-283-est
McCormick Reaffirms FY24 Sales Growth Outl...
03/26/2024 10:35:20

100-invested-in-this-stock-5-years-ago-would-be-worth-400-today
$100 Invested In This Stock 5 Years Ago Wo...
03/18/2024 16:00:35

which-stocks-will-dominate-the-future-of-tech-ubs-shares-its-top-picks-in-ai-healthtech-greentech-and-fintech
Which Stocks Will Dominate The Future Of T...
03/18/2024 07:14:12

In a recent report, global wealth manager UBS has identified the sectors that are likely to drive the next wave of technologica...

ubs-maintains-buy-on-mckesson-raises-price-target-to-620
UBS Maintains Buy on McKesson, Raises Pric...
03/06/2024 17:43:50

UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $575 to $620.

how-is-the-market-feeling-about-mckesson
How Is The Market Feeling About McKesson?
02/27/2024 13:45:23

if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-13000-today
If You Invested $1000 In This Stock 15 Yea...
02/26/2024 17:30:19

leerink-partners-initiates-coverage-on-mckesson-with-outperform-rating-announces-price-target-of-600
Leerink Partners Initiates Coverage On McK...
02/26/2024 13:45:46

Leerink Partners analyst Michael Cherny initiates coverage on McKesson (NYSE:MCK) with a Outperform rating and announces Pri...

us-federal-trade-commission-investigates-drug-shortages-amid-allegations-of-market-manipulation
US Federal Trade Commission Investigates D...
02/14/2024 18:25:53

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scru...

mizuho-maintains-neutral-on-mckesson-raises-price-target-to-505-report-released-on-8th-february-2024
Mizuho Maintains Neutral on McKesson, Rais...
02/09/2024 15:51:40

Mizuho analyst Ann Hynes maintains McKesson (NYSE:MCK) with a Neutral and raises the price target from $450 to $505.

medical-supplies-focused-mckesson-shares-fall-on-q3-earnings-performance-analyst-says-street-wanted-more
Medical Supplies-Focused McKesson Shares F...
02/08/2024 19:29:59

McKesson beats expectations with Q3 2024 sales of $80.9 billion, up 15%. U.S. Pharmaceutical Segment thrives, adjusted EPS at $...

citigroup-maintains-buy-on-mckesson-raises-price-target-to-575
Citigroup Maintains Buy on McKesson, Raise...
02/08/2024 16:20:10

Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price target from $530 to $575.

if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-3900-today
If You Invested $1000 In This Stock 5 Year...
02/08/2024 14:30:19

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION